BioSpace News Archive

The global Biophotonics Market is projected to reach USD 118.89 billion by 2027, according to a recent report by Emergen Research. The growing demand for this technology in the healthcare sector is driving the growth of the market.

Human epidermal development factor receptor 2 (HER2) is a gene that is connected to breast cancer improvement. Genes contain the recipes for various proteins expected by a cell to stay solid and capacity typically.

The genome engineering market has been anticipated to experience noteworthy growth opportunities in the forthcoming years. The increasing market growth has been primarily driven by different factors such as the growing number of genomics projects.

SHINE Technologies, LLC, a next-generation fusion technology company, announced Tom D’Orazio has joined as the CEO of Phoenix LLC.

LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, has launched the Small Cell Lung Cancer Patient Gateway.

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor events.

Palisade Bio (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced the closing of its previously announced underwritten public offering for gross proceeds of approximately $13.8 million, prior to deducting underwriting discounts and commissions and offering expenses.

Viracta Therapeutics, Inc. today announced that the International Association for Research on Epstein-Barr Virus and Associated Disease (EBV Association) has elected Viracta’s Chief Scientific Officer, Ayman Elguindy , Ph.D., to its Governing Board.

Aridis Pharmaceuticals, Inc. today reported financial and corporate results for its second quarter ended June 30, 2022.

Ambrx Biopharma Inc. today announced the appointment of Kate Hermans as interim Chief Executive Officer, replacing Feng Tian, Ph.D., effective immediately.